Cargando…
Changes in adenomyosis following elagolix vs leuprolide treatment in a patient with pelvic pain and infertility: A case report
Adenomyosis is a uterine form of endometriosis that poses unique challenges in the management of infertility. Severe pelvic pain and menorrhagia associated with these conditions are commonly managed with intramuscular injections of a gonadotropin-releasing hormone agonist (leuprolide acetate). Since...
Autores principales: | Barseghyan, Mariam, Theisen, J. Graham, Wang, Clara, Gavrilova-Jordan, Larisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937890/ https://www.ncbi.nlm.nih.gov/pubmed/36820400 http://dx.doi.org/10.1016/j.crwh.2023.e00484 |
Ejemplares similares
-
Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2021) -
Infertility and Adenomyosis
por: Campo, Sebastiano, et al.
Publicado: (2012) -
Fertility and Pregnancy Outcomes in Patients With Adenomyosis: Is Adenomyosis Synonymous With Infertility?
por: Calero, Maria Jose, et al.
Publicado: (2022) -
Elagolix in the treatment of endometriosis: impact beyond pain
symptoms
por: Archer, David F., et al.
Publicado: (2020) -
Elagolix: First Global Approval
por: Lamb, Yvette N.
Publicado: (2018)